[DPHARMA] QoQ Quarter Result on 30-Sep-2018 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
28-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Sep-2018 [#3]
Profit Trend
QoQ- 18.83%
YoY- 7.72%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 145,466 150,386 115,634 125,838 123,991 133,259 112,253 18.91%
PBT 18,316 18,786 17,658 15,838 12,915 13,255 12,825 26.90%
Tax -4,400 -4,321 -3,289 -3,552 -2,576 -2,608 -1,057 159.44%
NP 13,916 14,465 14,369 12,286 10,339 10,647 11,768 11.85%
-
NP to SH 13,916 14,465 14,369 12,286 10,339 10,782 11,870 11.21%
-
Tax Rate 24.02% 23.00% 18.63% 22.43% 19.95% 19.68% 8.24% -
Total Cost 131,550 135,921 101,265 113,552 113,652 122,612 100,485 19.73%
-
Net Worth 503,029 496,410 483,173 501,487 209,983 206,429 479,809 3.20%
Dividend
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Div 6,618 - 26,475 - 4,199 - 16,737 -46.21%
Div Payout % 47.56% - 184.25% - 40.62% - 141.01% -
Equity
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Net Worth 503,029 496,410 483,173 501,487 209,983 206,429 479,809 3.20%
NOSH 661,881 661,881 661,881 661,881 650,902 278,959 278,959 78.17%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 9.57% 9.62% 12.43% 9.76% 8.34% 7.99% 10.48% -
ROE 2.77% 2.91% 2.97% 2.45% 4.92% 5.22% 2.47% -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 21.98 22.72 17.47 19.07 44.29 47.77 40.24 -33.25%
EPS 2.07 2.19 2.17 1.86 1.59 3.82 4.22 -37.88%
DPS 1.00 0.00 4.00 0.00 1.50 0.00 6.00 -69.81%
NAPS 0.76 0.75 0.73 0.76 0.75 0.74 1.72 -42.07%
Adjusted Per Share Value based on latest NOSH - 661,881
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
RPS 15.11 15.62 12.01 13.07 12.88 13.84 11.66 18.91%
EPS 1.45 1.50 1.49 1.28 1.07 1.12 1.23 11.62%
DPS 0.69 0.00 2.75 0.00 0.44 0.00 1.74 -46.11%
NAPS 0.5225 0.5157 0.5019 0.5209 0.2181 0.2144 0.4984 3.20%
Price Multiplier on Financial Quarter End Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 -
Price 1.37 1.28 0.95 1.23 1.30 2.80 2.53 -
P/RPS 6.23 5.63 5.44 6.45 2.94 5.86 6.29 -0.63%
P/EPS 65.16 58.57 43.76 66.06 35.20 72.44 59.46 6.31%
EY 1.53 1.71 2.29 1.51 2.84 1.38 1.68 -6.06%
DY 0.73 0.00 4.21 0.00 1.15 0.00 2.37 -54.48%
P/NAPS 1.80 1.71 1.30 1.62 1.73 3.78 1.47 14.49%
Price Multiplier on Announcement Date
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Date 30/08/19 21/05/19 18/02/19 28/11/18 26/11/18 28/05/18 28/02/18 -
Price 1.41 1.36 1.03 1.07 1.08 3.35 2.97 -
P/RPS 6.42 5.99 5.90 5.61 2.44 7.01 7.38 -8.89%
P/EPS 67.06 62.23 47.45 57.47 29.25 86.67 69.80 -2.64%
EY 1.49 1.61 2.11 1.74 3.42 1.15 1.43 2.78%
DY 0.71 0.00 3.88 0.00 1.39 0.00 2.02 -50.29%
P/NAPS 1.86 1.81 1.41 1.41 1.44 4.53 1.73 4.96%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment